Benzyl 3,5-dioxopiperidine-1-carboxylate

Catalog No. :
ACGXAZ468
CAS No. :
1228631-19-3
Molecular Formula :
C13H13NO4
Molecular Weight :
247.25

IUPAC Name:benzyl 3,5-dioxopiperidine-1-carboxylate

Benzyl 3,5-dioxopiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$276.00Login to see priceIn stockInquiry
250mg95%$440.00Login to see priceIn stockInquiry
500mg95%$733.00Login to see priceIn stockInquiry
1g95%$1099.00Login to see priceIn stockInquiry
5g95%$3295.00Login to see priceIn stockInquiry
10g95%$5602.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 3,5-dioxopiperidine-1-carboxylate
IUPAC Namebenzyl 3,5-dioxopiperidine-1-carboxylate
MDL No.MFCD16618536
Molecular FormulaC13H13NO4
Molecular Weight247.25
SMILESO=C(N1CC(CC(C1)=O)=O)OCC2=CC=CC=C2
InChI KeyLWXKJIHFJCWJGM-UHFFFAOYSA-N
SynonymBENZYL 3,5-DIOXOPIPERIDINE-1-CARBOXYLATE | 1228631-19-3 | MFCD16618536 | 1-Piperidinecarboxylic acid, 3,5-dioxo-, phenylmethyl ester | 1-Cbz-piperidine-3,5-dione | SCHEMBL15067221 | LWXKJIHFJCWJGM-UHFFFAOYSA-N | DTXSID601246629 | AMY34032 | AKOS025290936 | SB11341 | AS-33952 | S
CAS No.1228631-19-3
PubChem CID49761164

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGXAZ468 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGXAZ468 route product structure diagram
    ACGXAZ4681228631-19-3 In Stock
Inquiry

2. ACGXAZ468 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGXAZ468 route product structure diagram
    ACGXAZ4681228631-19-3 In Stock
Inquiry

Comments (0)